Demant A/S (OTCMKTS:WILLF) Lowered to Underperform at Exane BNP Paribas

Exane BNP Paribas cut shares of Demant A/S (OTCMKTS:WILLF) from a neutral rating to an underperform rating in a report issued on Wednesday, The Fly reports.

Several other equities research analysts have also weighed in on WILLF. Credit Suisse Group raised Demant A/S from an underperform rating to a neutral rating in a research note on Friday, April 16th. Redburn Partners raised Demant A/S from a sell rating to a neutral rating in a research note on Friday, February 19th. Finally, SEB Equities raised Demant A/S from a hold rating to a buy rating in a research note on Wednesday, February 10th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company. The company presently has a consensus rating of Hold.

Shares of OTCMKTS WILLF opened at $51.30 on Wednesday. The stock has a fifty day moving average price of $46.42 and a two-hundred day moving average price of $39.68. Demant A/S has a 1 year low of $25.95 and a 1 year high of $54.10.

About Demant A/S

Demant A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. It operates through two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products.

Further Reading: How a Strangle Strategy is different from a Straddle Strategy

The Fly

Analyst Recommendations for Demant A/S (OTCMKTS:WILLF)

Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.